MBIO Mustang Bio Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: MBIO

Price (delayed)

$0.3178

Market cap

$3.3M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6

Enterprise value

-$1.18M

Mustang Bio, Inc. ("Mustang") is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare ...

Highlights
The company's debt has shrunk by 92% YoY and by 3% QoQ
MBIO's EPS is up by 41% year-on-year and by 23% since the previous quarter
MBIO's equity has dropped by 100% year-on-year and by 97% since the previous quarter
The quick ratio has shrunk by 86% YoY and by 2.7% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.mustangbio.com
Peers: OMER OMGA

Key stats

What are the main financial stats of MBIO
Market
Shares outstanding
10.39M
Market cap
$3.3M
Enterprise value
-$1.18M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
23.81
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$47.49M
EBITDA
-$45.27M
Free cash flow
-$43.54M
Per share
EPS
-$6
Free cash flow per share
-$5.06
Book value per share
$0.01
Revenue per share
$0
TBVPS
$2.06
Balance sheet
Total assets
$17.74M
Total liabilities
$17.62M
Debt
$2.5M
Equity
$123,000
Working capital
-$4.03M
Liquidity
Debt to equity
20.31
Current ratio
0.74
Quick ratio
0.71
Net debt/EBITDA
0.1
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-146.4%
Return on equity
-433.1%
Return on invested capital
-578.2%
Return on capital employed
-2,003.1%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MBIO stock price

How has the Mustang Bio stock price performed over time
Intraday
9.59%
1 week
-0.69%
1 month
-61.24%
1 year
-92.17%
YTD
-76.46%
QTD
-69.44%

Financial performance

How have Mustang Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$49.26M
Net income
-$51.6M
Gross margin
N/A
Net margin
N/A
MBIO's operating income is up by 35% YoY and by 18% from the previous quarter
MBIO's net income is up by 33% year-on-year and by 18% since the previous quarter

Growth

What is Mustang Bio's growth rate over time

Valuation

What is Mustang Bio stock price valuation
P/E
N/A
P/B
23.81
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
MBIO's EPS is up by 41% year-on-year and by 23% since the previous quarter
MBIO's equity has dropped by 100% year-on-year and by 97% since the previous quarter
The P/B is 14% below the last 4 quarters average of 27.6

Efficiency

How efficient is Mustang Bio business performance
The ROIC has plunged by 153% YoY and by 69% from the previous quarter
MBIO's ROA has plunged by 117% YoY and by 26% from the previous quarter
The company's return on equity has shrunk by 62% QoQ

Dividends

What is MBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MBIO.

Financial health

How did Mustang Bio financials performed over time
The quick ratio has shrunk by 86% YoY and by 2.7% QoQ
Mustang Bio's current ratio has shrunk by 86% YoY and by 23% QoQ
MBIO's equity has dropped by 100% year-on-year and by 97% since the previous quarter
The company's debt has shrunk by 92% YoY and by 3% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.